Ampio Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Net Income	-8.63	-16.34	-17.08	-15.89	-13.63	Upgrade
Depreciation & Amortization	0.13	1.05	1.09	1.18	1.27	Upgrade
Loss (Gain) From Sale of Assets	0.06	-	-	0.07	-	Upgrade
Asset Writedown & Restructuring Costs	-	1.94	-	-	-	Upgrade
Stock-Based Compensation	0.16	1.46	2.8	1.36	0.49	Upgrade
Other Operating Activities	-0.29	-6.26	-3.49	-0	-4.87	Upgrade
Change in Accounts Payable	1.25	-3.96	3.26	-2.48	2.7	Upgrade
Change in Other Net Operating Assets	-1.24	0.99	-0.68	1.03	-1.34	Upgrade
Operating Cash Flow	-8.56	-21.13	-14.09	-14.73	-15.38	Upgrade
Capital Expenditures	-	-	-0.1	-0.06	-0.02	Upgrade
Investing Cash Flow	-	-	-0.1	-0.06	-0.02	Upgrade
Issuance of Common Stock	0.1	-	33.25	26.97	16.02	Upgrade
Repurchase of Common Stock	-	-0.08	-0.19	-	-	Upgrade
Other Financing Activities	-0.1	-0.03	-2.33	-1.37	-1.66	Upgrade
Financing Cash Flow	-	-0.11	30.73	25.61	14.35	Upgrade
Net Cash Flow	-8.56	-21.24	16.55	10.81	-1.05	Upgrade
Free Cash Flow	-8.56	-21.13	-14.19	-14.79	-15.41	Upgrade
Free Cash Flow Per Share	-10.57	-28.04	-20.76	-25.67	-35.24	Upgrade
Levered Free Cash Flow	-5.37	-14.4	-6.04	-10.23	-7.34	Upgrade
Unlevered Free Cash Flow	-5.37	-14.4	-6.04	-10.23	-7.34	Upgrade
Change in Net Working Capital	-0.29	3.67	-3.02	2.8	-2.53	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.